A carregar...
Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis
Denosumab is a human monoclonal antibody which specifically blocks receptor activator of nuclear factor κB ligand and is a very potent antiresorptive drug. Its efficacy in reducing the risk of vertebral, hip and nonskeletal fracture has been proven in a large prospective, randomized multicenter stud...
Na minha lista:
| Publicado no: | Ther Adv Musculoskelet Dis |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4426099/ https://ncbi.nlm.nih.gov/pubmed/26029270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X15579189 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|